These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32877010)

  • 21. How physician obesity medicine specialists treated obesity before 2012 new drug approvals.
    Schmidt SL; Bryman D; Greenway FL; Hendricks EJ
    Obes Surg; 2015 Jan; 25(1):186-90. PubMed ID: 25344465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.
    Thomas CE; Mauer EA; Shukla AP; Rathi S; Aronne LJ
    Obesity (Silver Spring); 2016 Sep; 24(9):1955-61. PubMed ID: 27569120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of pharmacotherapy in the department of paediatric dentistry.
    Paudel KR; Sah NK; Jaiswal AK
    Kathmandu Univ Med J (KUMJ); 2010; 8(30):190-4. PubMed ID: 21209533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification, evaluation, and management of obesity in an academic primary care center.
    O'Brien SH; Holubkov R; Reis EC
    Pediatrics; 2004 Aug; 114(2):e154-9. PubMed ID: 15286251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on Pediatric Anti-obesity Medications-Current Landscape and Approach to Prescribing.
    Ahn YJ; Maya J; Singhal V
    Curr Obes Rep; 2024 Jun; 13(2):295-312. PubMed ID: 38689134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity Pharmacotherapy is Effective in the Veterans Affairs Patient Population: A Local and Virtual Cohort Study.
    Pendse J; Vallejo-García F; Parziale A; Callanan M; Tenner C; Alemán JO
    Obesity (Silver Spring); 2021 Feb; 29(2):308-316. PubMed ID: 33491308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Providing paediatric power wheelchairs in the USA then and now: a survey of providers.
    Kenyon LK; Schmitt J; Otieno S; Cohen L
    Disabil Rehabil Assist Technol; 2020 Aug; 15(6):708-717. PubMed ID: 31177895
    [No Abstract]   [Full Text] [Related]  

  • 28. Attitudes, experiences, and preferences of ophthalmic professionals regarding routine use of patient-reported outcome measures in clinical practice.
    Robertson AO; Tadić V; Rahi JS
    PLoS One; 2020; 15(12):e0243563. PubMed ID: 33275625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated blood pressure in youth in pediatric weight management programs in the Pediatric Obesity Weight Evaluation Registry (POWER).
    Binns HJ; Joseph M; Ariza AJ; Cuda SE; Skinner AC; Xu H; Tucker JM; Hampl SE; Santos M; Mayo S; King EC; Kirk S;
    J Clin Hypertens (Greenwich); 2022 Feb; 24(2):122-130. PubMed ID: 35099099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
    Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New treatment modalities for obesity.
    Grandone A; Di Sessa A; Umano GR; Toraldo R; Miraglia Del Giudice E
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):535-549. PubMed ID: 30086873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How physician obesity specialists use drugs to treat obesity.
    Hendricks EJ; Rothman RB; Greenway FL
    Obesity (Silver Spring); 2009 Sep; 17(9):1730-5. PubMed ID: 19300434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of Youth Presenting for Weight Management: Retrospective National Data from the POWER Study Group.
    Jasik CB; King EC; Rhodes E; Sweeney B; Mietus-Snyder M; Grow HM; Harris JM; Lostocco L; Estrada E; Boyle K; Tucker JM; Eneli IU; Woolford SJ; Datto G; Stratbucker W; Kirk S
    Child Obes; 2015 Oct; 11(5):630-7. PubMed ID: 26440387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity Pharmacotherapy.
    Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
    Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in Preventive Visits Among U.S. Youth Where Weight and Height Were Recorded: 2005-2016.
    Santo L; Rui P; Hales CM; Arem H; Ogden CL
    Am J Prev Med; 2019 Nov; 57(5):716-717. PubMed ID: 31630763
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
    Walter CP; Bleske BE; Dorsch MP
    J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive trends in paediatric renal biopsy service provision in the UK: a national survey and re-audit of paediatric renal biopsy practice.
    Gupta A; Campion-Smith J; Hayes W; Deal JE; Gilbert RD; Inward C; Judd BA; Krishnan RG; Marks SD; O'Brien C; Shenoy M; Sinha MD; Tse Y; Tyerman K; Mallik M; Hussain F;
    Pediatr Nephrol; 2016 Apr; 31(4):613-21. PubMed ID: 26525201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological management of obesity in pediatric patients.
    Boland CL; Harris JB; Harris KB
    Ann Pharmacother; 2015 Feb; 49(2):220-32. PubMed ID: 25366340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.